functional medicine and nutritional genomics - American Association ...

More documents

Recommendations

Info

AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS Mark Hyman has dedicated his career to identifying and addressing the root causes of chronic illness through a groundbreaking wholesystems medicine approach known as Functional Medicine. He is a family physician, a four-time New York Times bestselling author, and an internationally recognized leader in his field. Through his private practice, education efforts, writing, research, advocacy and public-policy work, he strives to improve access to Functional Medicine, and to widen the understanding and practice of it, empowering others to stop managing symptoms and instead treat the underlying causes of illness, thereby also tackling our chronic-disease epidemic. Dr. Hyman is Chairman of the Institute for Functional Medicine, and was awarded its 2009 Linus Pauling Award for Leadership in Functional Medicine. He is on the Board of Directors of The Center for Mind-Body Medicine, and a faculty member of its Food As Medicine training program. He is also on the Board of Advisors of Memhet Oz’s HealthCorps, which tackles the obesity epidemic by ‚educating the student body‛ in American high schools about nutrition, fitness and mental resilience. He is a volunteer for Partners in Health with whom he worked immediately after the earthquake in Haiti and continues to help rebuild the health care system there. He was featured on 60 Minutes for his work there. Dr. Hyman has testified before the White House Commission on Complementary and Alternative Medicine, and has consulted with the Surgeon General on diabetes prevention. He has testified before the Senate Working Group on Health Care Reform on Functional Medicine, and participated in the White House Forum on Prevention and Wellness in June 2009. Dr. Hyman was nominated by Senator Tom Harkin for the President’s Advisory Group on Prevention, Health Promotion and Integrative and Public Health, a 25-person group to advise the Administration and the new National Council on Prevention, Health Promotion and Public Health. With Drs. Dean Ornish and Michael Roizen, Dr. Hyman crafted and helped to introduce the Take Back Your Health Act of 2009 into the United States Senate, to provide for reimbursement of lifestyle treatment of chronic disease. He 52 continues to work in Washington on health reform, recently testifying before a Congressional hearing on Functional Medicine, nutrition and the use of detary supplements. Through his work with corporations, church groups, and government entities, such as CIGNA, the Veterans Administration, Google, American Express and Saddleback Church, he is helping to improve health outcomes and reduce costs around the world. He initiated and is a key participant in the ongoing development of a faith-based initiative that enrolled over 14,000 people at Saddleback Church in a healthy lifestyle program and research study. In recognition of his efforts, he was recently awarded The Council on Litigation Management’s 2010 Professionalism Award, citing individuals who have demonstrated leadership by example in the highest standard of their profession. He also received The American College of Nutrition 2009 Communication and Media Award for his contribution to promoting better understanding of nutrition science. He has been featured on The Dr. Oz Show, 60 Minutes, Larry King Live, CNN, and MSNBC. Dr. Hyman is founder and Medical Director of The UltraWellness Center in Lenox, Massachusetts, where he directs a team of physicians, nutritionists and nurses who utilize a comprehensive approach to health. Before starting his practice, he was co-Medical Director at Canyon Ranch Lenox, one of the world's leading health resorts. While at Canyon Ranch, he co-authored the New York Times bestseller Ultraprevention: The 6-Week Program That Will Make You Healthy for Life (Scribner) – winner of the Books for a Better Life Award honoring the best self-improvement books each year. He has since written UltraMetabolism: The Simple Plan for Automatic Weight Loss, and a companion public television special. His latest book and PBS special, The UltraMind Solution, a comprehensive approach for addressing the causes of mental illness and cognitive disorders, was released in January 2009. The Blood Sugar Solution book and companion PBS special will be released in March 2012, addressing the global epidemic of obesity, diabetes and cardiovascular disease. 2012
AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS Dr. Hyman graduated with a B.A. from Cornell University, and graduated magna cum laude degree from the Ottawa University School of Medicine. He completed his residency at University of San Francisco's program in Family Medicine at the Community Hospital of Santa Rosa. Contact Mark Hyman at info@drhyman.com or 413-637-9991. References: i http://www.cdc.gov/obesity/index.html ii Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010 Jan 20;303(3):235- 41. iii Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004 Jun 16;291(23):2847-50. iv Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010 Mar 25;362(12):1090-101. v Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005 Mar 17;352(11):1138-45. vi Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 6;357(23):2371-9. vii Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002 Dec 4;288(21):2709-16. viii Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999 Dec 10;53(9):1937-42. ix Key TJ, Spencer EA, Reeves GK. Symposium 1: Overnutrition: consequences and solutions for obesity and cancer risk. Proc Nutr Soc. 2009 Dec 3:1-5. x http://apps.nccd.cdc.gov/DDTSTRS/FactSheet.aspx (National Diabetes Fact Sheet 2007). 53 xi Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010 Feb 11;362(6):485- 93. xii Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59. xiii The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010. xiv The NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010. xv The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010. xvi BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009 Jun 11;360(24):2503-15. xvii Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. J Am Coll Cardiol. 2009 Sep 29;54(14):1303-8. xviii American College of Preventive Medicine. Lifestyle Medicine—Evidence Review. June 30, 2009. Available at: http://www.acpm.org/LifestyleMedicine.htm. Accessed September 18, 2009. xix Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008 Jun 10;117(23):3031-8. Review. xx Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of 2012
Page 1 and 2:
2012 AAPI’S NUTRITION GUIDE TO OP
Page 3 and 4:
AAPI’S NUTRITION GUIDE TO OPTIMAL
Page 5 and 6:
Page 7 and 8: AAPI’S NUTRITION GUIDE TO OPTIMAL
Page 57: AAPI’S NUTRITION GUIDE TO OPTIMAL
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
show all

functional medicine and nutritional genomics - American Association ...

Create successful ePaper yourself

Delete template?

Save as template?